跳至主要内容
临床试验/NCT00530400
NCT00530400已完成4 期

Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of Single-Dose Cefuroxime Prophylaxis in Herniated Disk Surgery

Centre Hospitalier Universitaire Vaudois2 个研究点 分布在 1 个国家目标入组 1,369 人开始时间: 1994年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
1,369
试验地点
2
主要终点
Occurrence of a surgical site infection

研究概览

简要总结

The purpose of the study is to determine whether a single, pre-operative dose of cefuroxime is effective in preventing surgical site infection in patients undergoing surgery for herniated disk

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age older than 18
  • spinal surgery for herniated disk

排除标准

  • known or suspected hypersensitivity to cephalosporins
  • type I hypersensitivity to betalactamic antibiotics
  • severe renal function impairment
  • acquired immune deficiency syndrome (AIDS) or other conditions of severe immuno-suppression
  • antibiotic therapy for concomitant infection at the time of surgery
  • pregnancy
  • refusal to participate

研究组 & 干预措施

1

Experimental

intravenous 1.5g cefuroxime

干预措施: cefuroxime (Drug)

2

Placebo Comparator

intravenous placebo

干预措施: placebo (Drug)

结局指标

主要结局

Occurrence of a surgical site infection

时间窗: 6 months

次要结局

  • Occurrence of a post-operative infection other than surgical site infection(6 monts)
  • Serious adverse event(6 months)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验